Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud’s phenomenon: An open-label, randomized, prospective pilot study

Detalles Bibliográficos
Autores principales: Lee, Kyung-ann, Jung, Seung-hwan, Kim, Jong-sun, Kim, Hyun-sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish League Against Rheumatism 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689017/
https://www.ncbi.nlm.nih.gov/pubmed/38046252
http://dx.doi.org/10.46497/ArchRheumatol.2023.9212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689017/
https://www.ncbi.nlm.nih.gov/pubmed/38046252
http://dx.doi.org/10.46497/ArchRheumatol.2023.9212

Ejemplares similares